DYN logo

DYN
Dyne Therapeutics Inc

2,685
Mkt Cap
$2.9B
Volume
5.06M
52W High
$25.00
52W Low
$6.36
PE Ratio
-4.96
DYN Fundamentals
Price
$17.56
Prev Close
$17.80
Open
$17.88
50D MA
$17.04
Beta
1.86
Avg. Volume
1.81M
EPS (Annual)
-$3.47
P/B
2.98
Rev/Employee
$0.00
$1,570.98
Loading...
Loading...
News
all
press releases
Dyne Therapeutics, Inc. $DYN Shares Bought by JPMorgan Chase & Co.
JPMorgan Chase & Co. raised its stake in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 9.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,365,245 shares of the company's stock after purchasing an additional 278,466...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Trading 4.4% Higher - Here's Why
Dyne Therapeutics (NASDAQ:DYN) Trading Up 4.4% - Here's What Happened...
MarketBeat·2d ago
News Placeholder
Dyne Therapeutics Targets 2026 Breakout Year With DMD BLA Plans and DM1 Milestones at Stifel Conference
Dyne Therapeutics (NASDAQ:DYN) executives outlined a slate of 2026 operational and regulatory milestones during a discussion with Stifel, emphasizing plans to transition toward a commercial-stage...
MarketBeat·3d ago
News Placeholder
Braidwell LP Sells 542,868 Shares of Dyne Therapeutics, Inc. $DYN
Braidwell LP trimmed its holdings in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 16.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·8d ago
News Placeholder
WINTON GROUP Ltd Makes New Investment in Dyne Therapeutics, Inc. $DYN
WINTON GROUP Ltd acquired a new stake in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·10d ago
News Placeholder
Insider Buying: Dyne Therapeutics (NASDAQ:DYN) Director Purchases 3,000 Shares of Stock
Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Brian Posner bought 3,000 shares of the business's stock in a transaction on Friday, March 6th. The stock was purchased at an average...
MarketBeat·12d ago
News Placeholder
Brian Posner Purchases 3,000 Shares of Dyne Therapeutics (NASDAQ:DYN) Stock
Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Brian Posner acquired 3,000 shares of the business's stock in a transaction dated Friday, March 6th. The stock was purchased at an...
MarketBeat·12d ago
News Placeholder
Chardan Capital Reiterates "Buy" Rating for Dyne Therapeutics (NASDAQ:DYN)
Chardan Capital reiterated a "buy" rating and set a $38.00 price target on shares of Dyne Therapeutics in a research note on Monday...
MarketBeat·13d ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Trading 11.2% Higher - Time to Buy?
Dyne Therapeutics (NASDAQ:DYN) Trading 11.2% Higher - Here's Why...
MarketBeat·13d ago
News Placeholder
HC Wainwright Predicts Higher Earnings for Dyne Therapeutics
Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) - Research analysts at HC Wainwright lifted their FY2026 EPS estimates for Dyne Therapeutics in a research report issued to clients and investors on...
MarketBeat·17d ago
<
1
2
...
>

Latest DYN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.